Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Todd S Barry
High Concordance Between Immunohistochemistry and Fluorescence in Situ Hybridization Testing for HER2 Status in Breast Cancer Requires a Normalized IHC Scoring System
Modern Pathology
Forensic Medicine
Pathology
Related publications
Review of HER2 Immunohistochemistry and in Situ Hybridisation Concordance in Breast Cancer
Pathology
Forensic Medicine
Pathology
Comparison of Immunohistochemistry and Fluorescence in Situ Hybridization for the Analysis of Her2/Neu and Topoisomerase Ii-Alpha Status in Human Breast Cancer
Turk Patoloji Dergisi
Forensic Medicine
Pathology
Assessment of HER2 Status in Breast Cancer: Overall Positivity Rate and Accuracy by Fluorescence in Situ Hybridization and Immunohistochemistry in a Single Institution Over 12 Years: A Quality Control Study
BMC Cancer
Cancer Research
Oncology
Genetics
Necessity of in Situ Hybridization Test of Human Epidermal Growth Factor Receptor 2 (HER2) Status in Breast Cancer Patients With Equivocal HER2 Immunohistochemistry Results
Journal of Breast Disease
Macrodissection Prior to Closed System RT-qPCR Is Not Necessary for Estrogen Receptor and HER2 Concordance With IHC/FISH in Breast Cancer
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Electron Microscopic Basis for Applications of Immunohistochemistry (IHC) and in Situ Hybridization (ISH) to Diagnostic Pathology.
Acta Histochemica et Cytochemica
Cell Biology
Biochemistry
Histology
Forensic Medicine
Pathology
Physiology
Expression of HER2 and the Coamplified Genes GRB7 and MLN64 in Human Breast Cancer: Quantitative Real-Time Reverse Transcription-PCR as a Diagnostic Alternative to Immunohistochemistry and Fluorescence in Situ Hybridization
Clinical Cancer Research
Cancer Research
Oncology
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study
European Journal of Breast Health
HER2-HER3 Dimer Quantification by FLIM-FRET Predicts Breast Cancer Metastatic Relapse Independently of HER2 IHC Status
Oncotarget
Oncology
